Medline Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Medline Inc in the third quarter 2026?
Medline Inc achieved a return on average equity (ROE) of 5.28 % in its third quarter 2026, this is above MDLN's average return on equity of 0%.
Medline Inc s equity during the 12 months ending in the third quarter 2026 are valued at $19 billion

ROE fell compared to the second quarter 2026, despite the net income growth of 128.78% from the second quarter 2026.

Within the Medical Equipment & Supplies industry Medline Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the second quarter 2026 at no. .

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 26 2026) III. Quarter	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 27 2025) III. Quarter
Y / Y Equity Change	17.32 %	-	-	-	-
Y / Y Net Income Change	0 %	-57.75 %	-97.81 %	-	-
Net Income (TTM) in Millions	1,018	1,018	1,208	17,649	17,456
Return On Equity (TTM)	5.28 %	5.49 %	8.76 %	197.14 %	422.56 %
MDLN's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	19,386	19,077	19,349	19,286	16,524
Seq. Equity Change	1.62 %	-1.41 %	0.33 %	16.72 %	-
Seq. Net Income Change	128.78 %	-62.23 %	90.67 %	-39.31 %	-3.34 %

Back to MDLN Management Effectiveness >> MDLN's 5 Years Annual ROE >> Compare MDLN ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

MDLN Annual Return On Equity	(Dec 31 2025) 2025
Total Equity in Millions	19,286	0	0	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	1,161	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	6.02 %	-	-	-	-

Back to MDLN Management Effectiveness >> MDLN's 5 Years Annual ROE >> Compare MDLN ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 6.02 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MDLN's' Return on Equity at Yahoo Finance
MDLN's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MDLN's Competitors
Subscribers only: Roe for Medline Inc 's Suppliers
Subscribers only: Return On Equity for MDLN's Customers

Companies with similar Return On Equity at Sep 26 2026, within Healthcare Sector	ROE
Bio rad Laboratories Inc	14.07 %
Boston Scientific Corporation	13.75 %
Inspire Medical Systems inc	12.49 %
Haemonetics Corporation	12.07 %
Labcorp Holdings Inc	11.55 %
Henry Schein Inc	11.29 %
Medinotec Inc	10.97 %
Tactile Systems Technology Inc	10.73 %
Penumbra Inc	10.44 %
Teleflex Incorporated	9.67 %
Merit Medical Systems Inc	9.65 %
U S Physical Therapy Inc	9.48 %
Pacific Health Care Organization Inc	8.10 %
Incyte Corporation	7.08 %
Conmed Corporation	7.07 %
Teva Pharmaceutical Industries Limited	6.37 %
Integer Holdings Corporation	6.02 %
Avantor Inc	5.96 %
Ligand Pharmaceuticals Incorporated	5.22 %
Lifestance Health Group Inc	4.82 %
Jazz Pharmaceuticals Plc	4.62 %
Pfizer Inc	4.62 %
Innovage Holding Corp	4.52 %
Icu Medical Inc	2.81 %
Biogen Inc	1.86 %
Integra Lifesciences Holdings Corp	1.24 %

Date modified: 2026-11-06T13:07:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.